Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium Nitrite

NCT04401527 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped No recruitment

Conditions

COVID-19
Acute Respiratory Distress Syndrome
Acute Respiratory Failure

Interventions

DRUG: Sodium Nitrite
DRUG: Normal Saline

Sponsor

Hope Pharmaceuticals